Japan Intellectual Property Rights: ANTI-TSLP NANOBODIES AND USES THEREOF

Japan, Sept. 30 -- SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD has got intellectual property rights for 'ANTI-TSLP NANOBODIES AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2025-184109

Category (FI): A61P37/02,C07K19/00,C12P21/02@C,C12M1/34@F,A61K39/395@U,A61K39/395@L,A61K47/68,A61P43/00,111,A61K38/43,A61K38/19,A61K47/69,A61P35/00,A61K49/00,C07K16/24,C12N15/13,A61P11/06,A61P37/08,A61K51/10,200,A61K39/395@N,C12R1:84,G01N33/531@A,G01N33/53@P,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10,C12P21/08,C07K16/46

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 31, 2025

Publication Date: Feb. 10

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100...